Can Sun Pharma's quarterly show reinforce investor confidence in stock?The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when ...
USFDA pulls up Sun Pharma for lapses in Halol plant"This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceutica...
MG Motor India to invest Rs 4,000 crore for a second manufacturing plantWhen asked about the investment and production capacity for the second plant, he said, "We are looking for close to Rs 4,000 crore for the ...
MG Motor India to shut Halol manufacturing unit for 7 days to curb COVID-19 spread"We have decided to close our plant in Halol @Vadodra for seven days to break the chain of COVID. And our employees are committed to stay s...
Sun Pharma skids 3% after USFDA issues 8 observations to Halol plantHalol plant is one of the largest facilities contributing to US sales.
Ceat lines up Rs 3,500 crore capex to ramp up production capacityThe RPG Enterprise flagship firm said it has already put in capital to expand its Halol plant.
MG Motor to drive in electric SUV in India by first half of 2020The company, also plans to launch a mid-sized SUV with petrol and diesel powertrains in the second quarter of 2019.
If Sun Pharma inspections come through, 2018 could be a turning point for Indian pharma: Amit Rajan, Prosfora Technology“We have to get our things in order for sterile manufacturing and Sun Pharma Halol plant is mostly on steriles.”
General Motors India-SAIC deal gets Competition Commission's nodThe Chinese company, which has been planning to enter the Indian market, has proposed to buy certain assets of GM's India's Halol plant in ...
Sun Pharma EPS may fall by up to 6% on USFDA notice on Halol plantThe US FDA issued the notice on Tuesday with nine inspectional observations after an onsite inspection of Sun Pharma’s Halol facility in Gu...
FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
For Sun Pharma, a lot rides on USFDA's report on Halol PlantThe Sun Pharma stock has appreciated 13% since the announcement of its second quarter performance on November 10.
Sun Pharma rises 2% as USFDA issues 7 observations on Mohali sitePrabhudas Lilladher said the current price still does not reflect key positives like Ranbaxy integration benefits, Halol plant resolution a...
Sun Pharma's problems to continue for another 2-3 quartersThe company's Halol plant has been under the scanner of US Food and Drug Administration (USFDA) for alleged violations of good manufacturin...
Sun Pharma shares a good buy despite short-term painStock may see a sell-off on earnings downgrades & FDA warning, but co has not revised revenue guidance & FIs have steadily raised holdings.
Ceat Q2 profit at Rs 77 cr; to invest Rs 650 crore on Halol plantThe company is planning to invest Rs 650 crore to expand its Halol-based manufacturing facility. Its Sri Lankan operations too apparently c...